Raue has advised Lauxera Capital Partners on the due diligence of its 50 million Euro investment in Acandis GmbH. Acandis is a leading German neurovascular medical technology company specialising in the prevention and treatment of strokes.
The Lauxera and Acandis transaction represents Lauxera’s first investment from its second-generation healthcare growth buyout fund, Lauxera Growth II.
About Lauxera Capital Partners:
Lauxera Capital Partners, founded in 2020, has established itself as a leading transatlantic investment firm in the healthcare sector and currently manages over 600 million Euro.
About Acandis:
Acandis was founded in 2006 by Dr Andreas and Kirsi Schuessler and is today a leading neurovascular medical technology company with global business operations in over 60 countries.
(20 February 2025)